13 site specific articles 13 site specific articles Adult patients (age 15+) Adult patients (age 15+) Survival by subsite, tumour morphology, stage Survival.

Slides:

Advertisements

Similar presentations

High Resolution Italian studies Pamela Minicozzi Descriptive Studies and Health Planning Unit, Department of Preventive and Predictive Medicine, Fondazione.

Advertisements

Cancer Registration and Health Service Regulation Dr Jenifer A E Smith.

FROM EUROCHIP-1 TO EUROCHIP-2 EUROCHIP-2 - The action Public Health Program EUROPEAN COMMISSION: HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL.

Improving Cancer Outcomes at a national level - The story from England Professor Sir Mike Richards National Cancer Director June

EUROCHIP-2 the action Health Indicators for Monitoring Cancer in Europe Public Health Program EUROPEAN.

Nicola Barnstaple Programme Manager. Key challenges in Scotland Increasing cancer incidence – predicted 35,000 cases per year in 2020 Ageing population.

Prostate Cancer Craig Blundred. Overview Disease Definition  Epidemiological Classification  Symptoms Disease Burden  Incidence  Mortality  Health.

Lung Cancer. Lung Cancer Incidence 1950s Male/Female ratio 6:1, this is now 7:5. (decreasing male smoking rates, increasing female smoking rates). Approximately.

The National Cancer Intelligence Network An overview Professor David Forman Professor of Cancer Epidemiology, University of Leeds NCIN – Lead for Information.

How is place of death for cancer patients changing and what affects it? UKACR Conference September 28 th 2004 Elizabeth Davies Karen Linklater Ruth Jack.

Prognostic factors for breast cancer survival in affluent and deprived areas Jasmina Stefoski-Mikeljevic.

Update on the Belgian Cancer Registry, breast cancer data... Belgian Breast Meeting 3-4/10/2008 Liesbet Van Eycken.

The All Breast Cancer Report was published in October breastscreen/research.html#breast- cancer-report.

Status of cancer in Europe Now ESMO, 9-10 October 2010 Dr. Andrea Micheli Director Descriptive Studies and Health Planning Unit Fondazione IRCCS “Istituto.

Henrik Møller, Carolynn Gildea, David Meechan, Greg Rubin, Thomas Round, Peter Vedsted Cancer Epidemiology and Population Health, KCL (HM) Public Health.

© Cancer Research UK 2004 Registered charity number Figure One: Five-year age-standardised relative survival (%), adults diagnosed , England.

Recent advances in the management of colorectal cancer Vilnius, May 6-7 Epidemiology of colorectal cancer: what we can learn from Lithuania Juozas Kurtinaitis.

RARECARE project Cancer registries and rare cancers: quality of data, supplementary information RARECARE WP6, 3 rd meeting th National Institute of Public.

1 Key concepts, data, methods and results Index Trends in cancer survival by ethnic and socioeconomic group, New Zealand, Soeberg M, Blakely.

High Resolution Studies within the European Cancer Information System Cooperation with EPAAC Riccardo Capocaccia Istituto Superiore di Sanità (ISS), Italy.

Health Consultation: Evaluation of Cancer Incidence in Census Tracts of Attleboro and Norton, Massachusetts: Suzanne K. Condon Associate Commissioner.

Kathrin Strasser-Weippl 1 st Medical Department Wilhelminen Hospital, Vienna Cancer Care in Europe.

National Program of Cancer Registries

What’s on the Horizon Anita Corrigan Nurse Director

 Cancer is a group of more than 100 diseases that develop over time › Involve the uncontrolled division of the body’s cells  Cancer is the 2 nd leading.

Statistics about unknown primary tumors Riccardo Capocaccia National Centre for Epidemiology, Surveillance and Health Promotion Istituto Superiore di Sanità,

Information network on rare cancers INFORMATION NETWORK ON RARE CANCERS (RARECARENet) Kick-off meeting - Friday, July Gemma Gatta Fondazione IRCCS,

Cancer survival in the UK and Republic of Ireland B Rachet 1, M Quinn 2, D Brewster 3, A Gavin 4, J Steward 5, H Comber 6, L Gonsalves 7, V Mak 8, MP Coleman.

© Cancer Research UK 2005 Registered charity number Table One: Numbers and rates of new cases, non-Hodgkin lymphoma, UK, 2006 EnglandWalesScotlandN.IrelandUK.

Slides last updated: October Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality.

European Union against cancer The EUROCHIP project 1st International Cancer Control Congress Vancouver, October 2005 Public Health Program EUROPEAN.

Adolescent and Young Adult Oncology Scientific Meeting 2013 Epidemiology Working Group.

Chester Ellesmere Port & Neston Rural Making sure you get the healthcare you need West Cheshire CCG Strategy Dr Andy McAlavey Medical Director West Cheshire.

Associated Web sites CustomizableMaps The Atlas On-Line.

Algeria Croatia EgyptFranceGreece ItalyJordanLebanonLybiaMorocco PortugalSyriaSloveniaSpainTunisiaTurkeyPalestine Albania Cyprus MacedoniaMalta Mediterranean.

Dr Heather O Dickinson Department of Child Health University of Newcastle

Information network on rare cancers Work Package 4 Information on epidemiology of rare cancers Riccardo Capocaccia and Sandra Mallone Cancer Epidemiology.

Delivering clinical research to make patients, and the NHS, better Cancer Patients’ Experiences of Research Findings from the National Cancer Patient Experience.

EUROCHIP-Italia in EUROCHIP-2 Health Indicators for Monitoring Cancer in Europe Public Health Program EUROPEAN COMMISSION: HEALTH & CONSUMER PROTECTION.

THE EFFECT OF AGE ON OUTCOME OF SYNOVIAL SARCOMA PATIENTS A DUTCH POPULATION BASED STUDY Myrella Vlenterie, SEJ Kaal, VKY Ho, R Vlenterie, WTA van der.

Supporting people with active and advanced disease Need better data collection Discussion at MDT – new diagnosis support Identify best practice Early palliative.

Lymphoma Rob Jones. Aim and learning outcomes Aim ◦ To revise the key points of lymphoma Learning outcomes ◦ Revise the basics of haemopoiesis ◦ Understand.

Anne Snow, Lead Cancer Nurse Dr Andrew Woolley – Consultant Physician.

National Cancer Survivorship Initiative Ciarán Devane Chief Executive, Macmillan Cancer Support.

FRENCH high-resolution studies - Breast cancer: 1990, 1997, 2003, 2010 ? - Colorectal cancer: 1990, 1995, 2000, 2005, 2010 ? - Prostate cancer: 1995,

National Cancer Intelligence Network Outcome and the effect of age in 1318 patients with synovial sarcoma: Report from the National Cancer Intelligence.

What is the London cancer landscape? Report on London cancer intelligence Prepared by Katherine Henson, National Cancer Intelligence Network, QA by Ruth.

The Cancer Registry of Norway Jan F Nygård Head of the IT-department.

Cancer in Ontario: Overview A Statistical Report.

What the cancer tools show for London Vivian Mak National Cancer Intelligence Network London Public Health Knowledge and Intelligence Network meeting Wednesday.

Developed from information included in the AIHW report Cancer in Australia: in brief 2014 Highlights.

Where can I find data on cancer? Victoria H Coupland London Knowledge and Intelligence Team 20 February 2014.

Haematological malignancy research network © April 2014.

Helicobacter pylori and Gastric Lymphoma

RARECARE project Proposal for improving data quality on rare cancers with high priority Granada, March 25 th 2009 Andalusian School of Public Health.

Incidence Childhood cancer is rare - around 1,600 new cases are diagnosed every year in the UK (in children aged 0 to 14 years). This means that around.

Variation in place of death from cancer: studies in South East England Elizabeth Davies, Peter Madden, Victoria Coupland, Karen Linklater, Henrik Møller.

Scottish Renal Cancer Forum National Meeting 31st March 2016 Renal cancer survival Period of diagnosis: Roger Black.

Survival in most affluent

Distribution of diagnoses among the nearly 115,000 cases of lymphoid malignancy diagnosed in There are 5400 cases of acute lymphoid leukemia (ALL),

Haematological Cancers:

2 Incidence Ontario Cancer Statistics 2016 Chapter 2: Incidence.

Thyroid Cancer Survival – Population based study – EUROCARE-5

SWAG SSG Haematology and Lymphoma Meeting

5 Prevalence Ontario Cancer Statistics 2016 Chapter 5: Prevalence.

NHS Breast Screening Programme

The 20 Most Common Cancers in 2012

It is estimated that more than 1

In focus – Emerging issues in cancer control

Geographical and temporal differences in gastric and oesophageal cancer in Europe

Presentation transcript:

13 site specific articles 13 site specific articles Adult patients (age 15+) Adult patients (age 15+) Survival by subsite, tumour morphology, stage Survival by subsite, tumour morphology, stage Country-specific survival Country-specific survival Time trends incidence and survival Time trends incidence and survival

Between country differences in cancer survival

Chronic Myeloid Leukemia 5-year relative survival by country and region 52,9 (51,6 – 54,2) Northern Europe Ireland and UK Central Europe Southern Europe Eastern Europe

Haematological malignancies Time trends in age-standardized 5-y RS Hodgkin's lymphoma Chronic lymphocytic leukaemia/ small lymphocytic lymphoma Follicular lymphoma Diffuse large B-cell lymphoma Multiple myeloma/plasmacytoma Chronic myeloid leukaemia

Average Total National Expenditure on Health (TNEH) and tertiles of 5-y age-and case-mix adjusted relative survival for all cancer cases diagnosed in Average TNEH per capite $ Purchasing Power Parity y relative survival tertiles for all cancer cases diagnosed in R 2 log-linear regression 73%

EUROCARE 5 KEY MESSAGES Continuous improvements in cancer survival over time, but persisting variations across countries and regions point inequalities in the access and availability of adequate cancer care variations in survival related to combination of: - differences in cancer biology (stomach, head & neck) -diagnostic intensity and screening (breast, colorectal, prostate), which are reflected in earlier stage at diagnosis -availability of effective treatments (haematological malignancies) -socioeconomic status, lifestyle and general health differences between populations Population-based survival information deriving from CR allows monitoring cancer survival trends, but further investigation are needed: Better tumour characterisation Comorbidity and its influence on the prognosis Survivorship Cancer costs and organization of care we must continue to urge Member States to ensure that public health research shall not be impeded by the new proposal on the General Data Protection Regulation